ABSTRACT NUMBER: ESOC2026A1799 BRIDGING VERSUS DIRECT THROMBECTOMY IN MEDIUM VESSEL OCCLUSION STROKE. A SYSTEMATIC REVIEW AND META-ANALYSIS

Abstract Background and aims Medium vessel occlusions (MeVOs) represent nearly 30% of acute ischemic strokes, yet optimal management remains uncertain. These strokes often present with milder deficits, distal occlusions, and smaller clot burdens, suggesting potential benefit for intravenous thrombolysis (IVT) as an adjunct to mechanical thrombectomy (MT). This study compares outcomes between bridging therapy (IVT plus MT) and direct MT in MeVO-related stroke. Methods A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted from inception to December 2025. Studies comparing bridging therapy versus direct MT in MeVO-related stroke patients were included. Efficacy outcomes included a favorable functional outcome, defined as a modified Rankin Scale (mRS) score of 0–2 at 90 days, and successful recanalization. Safety outcomes comprised all-cause mortality and intracranial hemorrhage (ICH). Pooled estimates were calculated using random-effects models. Results Three comparative studies including 1,001 patients were included. No significant differences were observed between the two groups in favorable functional outcomes (mRS 0–2) at 90 days (OR 1.99, 95% CI 0.58–6.80; p = 0.27) or in rates of successful recanalization (OR 1.69, 95% CI 0.76–3.74; p = 0.20). Similarly, the incidence of ICH and all-cause mortality did not differ significantly between groups (OR 1.29, 95% CI 0.77–2.18; p = 0.34; and OR 0.81, 95% CI 0.45–1.45; p = 0.48, respectively). Conclusions In MeVO-related stroke, bridging therapy offered no significant advantage over direct thrombectomy in functional outcomes, recanalization, safety, or mortality, suggesting direct MT alone may be sufficient. larger randomized trials are needed to confirm these findings. Conflict of interest Rashad G. Mohamed.nothing to disclose Amir Hegazi.nothing to disclose Mohamed Ehab Eldesoky.nothing to disclose Khalid sarhan.nothing to disclose Magdy shehab.nothing to disclose Mostafa Meshref.nothing to disclose

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1656
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1799 BRIDGING VERSUS DIRECT THROMBECTOMY IN MEDIUM VESSEL OCCLUSION STROKE. A SYSTEMATIC REVIEW AND META-ANALYSIS

Magdy Shehab, Khalid Sarhan, Rashad G. Mohamed, Amir Hegazi et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A1799 BRIDGING VERSUS DIRECT THROMBECTOMY IN MEDIUM VESSEL OCCLUSION STROKE. A SYSTEMATIC REVIEW AND META-ANALYSIS

Magdy Shehab, Khalid Sarhan, Rashad G. Mohamed, Amir Hegazi, Mohamed Ehab Eldesoky, Mostafa Meshref
article en

Abstract

Abstract Background and aims Medium vessel occlusions (MeVOs) represent nearly 30% of acute ischemic strokes, yet optimal management remains uncertain. These strokes often present with milder deficits, distal occlusions, and smaller clot burdens, suggesting potential benefit for intravenous thrombolysis (IVT) as an adjunct to mechanical thrombectomy (MT). This study compares outcomes between bridging therapy (IVT plus MT) and direct MT in MeVO-related stroke. Methods A systematic search of PubMed, Embase, Scopus, and the Cochrane Library was conducted from inception to December 2025. Studies comparing bridging therapy versus direct MT in MeVO-related stroke patients were included. Efficacy outcomes included a favorable functional outcome, defined as a modified Rankin Scale (mRS) score of 0–2 at 90 days, and successful recanalization. Safety outcomes comprised all-cause mortality and intracranial hemorrhage (ICH). Pooled estimates were calculated using random-effects models. Results Three comparative studies including 1,001 patients were included. No significant differences were observed between the two groups in favorable functional outcomes (mRS 0–2) at 90 days (OR 1.99, 95% CI 0.58–6.80; p = 0.27) or in rates of successful recanalization (OR 1.69, 95% CI 0.76–3.74; p = 0.20). Similarly, the incidence of ICH and all-cause mortality did not differ significantly between groups (OR 1.29, 95% CI 0.77–2.18; p = 0.34; and OR 0.81, 95% CI 0.45–1.45; p = 0.48, respectively). Conclusions In MeVO-related stroke, bridging therapy offered no significant advantage over direct thrombectomy in functional outcomes, recanalization, safety, or mortality, suggesting direct MT alone may be sufficient. larger randomized trials are needed to confirm these findings. Conflict of interest Rashad G. Mohamed.nothing to disclose Amir Hegazi.nothing to disclose Mohamed Ehab Eldesoky.nothing to disclose Khalid sarhan.nothing to disclose Magdy shehab.nothing to disclose Mostafa Meshref.nothing to disclose

European Stroke JournalVol. 11(Supplement_1)
Mansoura University (EG), Al-Azhar University (EG)
Good health and well-being
Openalex Percentile: Top 8%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.